biotech
Bio-AnalystSupplement research
person

Omega-3

Selected research topic

Sleep

The confirmed comparison studies tested several ingredients together. They cannot isolate the effect of this ingredient.

Publications for this topic
1
Human comparison publications
1
Publications needing review
0

Findings in the studies

  • factor III (frequent dreaming) scores

    • Comparison result:A better result than the comparison group was reported.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      General population · Combination study · 12 weeks
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • General population
      • Secondary outcome
      • Between-group comparison
      • Timepoint: 12 weeks
      • Study comparison: DHA plus EPA versus corn oil placebo; OSA-MA factor III (frequent dreaming) score
Representative outcome and study details

Human studies reported between-group improvement in factor III (frequent dreaming) scores.

combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · between-group comparison

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 50.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of the evidence centers on contextual or measured outcomes rather than general-use effects, limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 115

Papers linked to this topic 1 · distinct papers 1 · papers with a confirmed human comparison 1 · papers needing additional review 0

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • factor III (frequent dreaming) scores: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

What the research found

factor III (frequent dreaming) scores

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No combination cautions are available to show in the current data. This does not guarantee safety.

Review 2 combination findings and 0 findings that outperformed an ingredient alone.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

비타민 DCombined vitamin D and omega-3 fatty acids showed a 31% reduction in autoimmune disease incidence compared to placebo, suggesting a potential additive effect.
알파리포산The combination of omega-3 fatty acids and alpha-lipoic acid showed significant benefits in slowing cognitive and functional decline compared to placebo or omega-3 alone.